The Swedish Drug Delivery Center (SweDeliver)
| Reference number | |
| Coordinator | Uppsala universitet - Institutionen för farmaci |
| Funding from Vinnova | SEK 33 945 000 |
| Project duration | January 2020 - December 2024 |
| Status | Completed |
| Venture | Competence centre |
| Call | Kompetenscentrum 2020 |
Important results from the project
Through excellent research and the recruitment of international talent, SweDeliver has become a world-leading competence center in pharmaceutical formulation. Education has been a key focus, for PhD students/Postdocs and master’s students, as well as lifelong learning for everyone partaking in SweDeliver. Focus has been the development of new, sustainable lab methods and knowledge transfer between academia and industry. Several activities aimed at the general public have also been carried out.
Expected long term effects
As the development costs for new medications increase, the need for platforms where academia and industry can meet and collaborate also rises. SweDeliver has achieved this, and several new collaborations have been initiated. Further, it is also important to ensure the competence supply in pharmaceutical formulation in Sweden. Through the education of master’s students and PhD students, all of whom have chosen to start their careers in the Nordic region, SweDeliver has contributed to this.
Approach and implementation
The project progressed largely according to schedule, however with a slight delayed start due to the COVID-19 pandemic. Some PhD/Postdoc projects were also extended due to lengthy recruitment processes, parental and sick leave. The center has been highly active since start, which indicates that the selected activities have been the right ones. To enable as maximum participation, we have strived to ensure virtual activities, which has been highly appreciated by our industry partners.